Spatial transcriptomic analysis of 4NQO-induced tongue cancer revealed cellular lineage diversity and evolutionary trajectory [0.03%]
空间转录组分析揭示了4NQO诱导的舌头癌症中的细胞谱系多样性和进化轨迹
Feng Liu,Xiaojun Wu,Shaoqing Yu et al.
Feng Liu et al.
Introduction: Spatial transcriptomic analysis has proposed valuable insights into the behavior of tongue cancer. However, the specific cell types involved in chemically-induced carcinogenesis and the process of tumor deve...
Shurong Liu,Junling Zhang,Xin Wang
Shurong Liu
Metastasis of bladder cancer to the stomach was rarely reported before. We reported a case of a 68-year-old woman with metastatic bladder cancer to the stomach. The patient was diagnosed with epithelial cell carcinoma of the bladder and und...
Oral contrast-enhanced ultrasonographic features and radiomics analysis to predict NIH risk stratification for gastrointestinal stromal tumors [0.03%]
口服造影增强超声特征及影像组学分析预测胃肠道间质瘤NIH风险分级
Fan Yang,Chun-Wei Liu,Dai Zhang et al.
Fan Yang et al.
Objective: To evaluate the value of oral contrast-enhanced ultrasonography and radiomics analysis in predicting the National Institutes of Health (NIH) staging of gastrointestinal stromal tumors (GISTs). ...
Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02) [0.03%]
经导管动脉化疗栓塞联合阿帕替尼治疗晚期肝细胞癌的疗效和安全性：真实世界前瞻性多中心研究(Ahend-HAP02)
Hang Yuan,Zhen Li,Guang-Shao Cao et al.
Hang Yuan et al.
Purpose: To analyze the efficacy and safety of transarterial chemoembolization (TACE) with apatinib (TACE-A) for the treatment of advanced hepatocellular carcinoma (HCC). ...
Immune checkpoint inhibitor therapy for advanced HPV-related penile squamous cell carcinoma: a rare case report [0.03%]
晚期HPV相关性 Penis 癌采用免疫检查点抑制剂治疗的罕见病例报告
Zhen-Kun Pan,Meng-Hua Wu,Hua Shi et al.
Zhen-Kun Pan et al.
Background: Human papillomavirus type 16 (HPV-16)-associated penile squamous cell carcinoma (PSCC) poses considerable therapeutic challenges, especially in its advanced stages. Although surgery continues to be the corners...
The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker [0.03%]
METTL3通过m6A修饰对膀胱癌的影响：潜在的治疗靶点和预后生物标志物
Dong Wen,Pengcheng Fu,Geliu Shuai et al.
Dong Wen et al.
Bladder cancer (BCa) is one of the most prevalent malignant tumors globally, particularly among men. According to data from the Global Cancer Research Agency, the annual incidence of BCa continues to rise, and its clinical features are comp...
Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study [0.03%]
可手术膀胱尿路上皮癌根治术后预后预测列线图的建立和验证：多中心回顾性研究
Junjie Ji,Zengjin Wen,Yu Yao et al.
Junjie Ji et al.
Purpose: This study aimed to construct and validate nomograms for the prediction of overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) in patients with resectable bladder urothelial car...
Cyclin D2 - a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis [0.03%]
基于甲基化芯片和生物信息学分析的cyclin d2作为子宫体子宫内膜癌潜在生物标志物的可能性研究
Lizhen Wang,Wu Qu,Zhifu Yang
Lizhen Wang
Background: The incidence and mortality of uterine corpus endometrial carcinoma (UCEC) is increasing. Despite advances in diagnosis and treatment, the fundamental molecular mechanisms remain unclear to some extent. In thi...
Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer [0.03%]
利用MR-LINAC进行立体定向前列腺癌寡转移灶总消融放射治疗
Darren Mc Poon,Jing Yuan,Oi Lei Wong et al.
Darren Mc Poon et al.
Objectives: To prospectively investigate the feasibility, toxicity, and preliminary clinical outcomes of magnetic resonance (MR)-guided stereotactic total ablative radiotherapy (MRgSTAR) for simultaneous treatment of the ...
Correction: Case Report: Remarkable and sustained remission of an anaplastic thyroid carcinoma patient to the combined treatment of multimodal radiotherapy, anlotinib and toripalimab [0.03%]
订正：个例报道：多模态放射治疗、阿帕替尼和特瑞普利单抗联合治疗一个间变性甲状腺癌患者的显著且长期的缓解案例
Yurou Xing,Xuehu Wu,Zhihui Li et al.
Yurou Xing et al.
[This corrects the article DOI: 10.3389/fonc.2025.1491918.]. Keywords: anaplastic thyroid carcinoma; antiang...
Published Erratum
Frontiers in oncology. 2025 Jul 3:15:1649567. DOI:10.3389/fonc.2025.1649567 2025